Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$437,010
-$46,743 QoQ
Shares Held
3,459
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,445
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $100,006,894 across 14 Drug Manufacturers - General names. GILD ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,430 | $35,299,227 | |
| 2 | JNJ |
Johnson & Johnson
|
89,578 | $22,750,124 | |
| 3 | ABBV |
AbbVie Inc.
|
72,344 | $18,204,644 | |
| 4 | MRK |
Merck & Co., Inc.
|
136,408 | $17,528,428 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
37,785 | $2,177,171 | |
| 6 | NVS |
Novartis AG
|
7,847 | $1,229,781 | |
| 7 | PFE |
Pfizer Inc
|
50,191 | $1,208,599 | |
| 8 | AMGN |
Amgen Inc
|
2,744 | $993,657 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $437,010 | 3,459 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $483,753 | 3,471 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $389,085 | 3,170 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $352,869 | 3,179 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $281,831 | 2,542 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $268,920 | 2,400 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $221,688 | 2,400 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $201,216 | 2,400 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $164,664 | 2,400 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $175,800 | 2,400 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $214,271 | 2,645 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $198,216 | 2,645 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $203,850 | 2,645 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $219,455 | 2,645 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $237,804 | 2,770 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $121,529 | 1,970 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $59,955 | 970 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $57,666 | 970 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $70,431 | 970 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $67,754 | 970 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $66,794 | 970 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $62,691 | 970 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $56,512 | 970 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $684,689 | 8,899 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $611,163 | 8,175 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||